NCT02060916View on ClinicalTrials.gov

Study to Evaluate the Safety and Efficacy of PAZ320 in Patients With Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Type 2 Diabetes Treated With Insulin
Interventions
DRUG

PAZ320

Single-center pilot study, open label dose escalation design

Trial Locations (1)

03755

Dartmouth-Hitchcock Medical Center, Jefferson

Sponsors
All Listed Sponsors
lead

Boston Therapeutics

INDUSTRY